Tuttiquotidiani is completely free. Every day we aggregate news from 100+ sources and generate original AI summaries for you. Help us keep the service running with a small donation, or become TQ Pro for just €1/month.

Ascendis plans a once-monthly obesity drug after its Novo deal ends

  • Posted on September 14, 2026
  • By Google News
  • 0 Views
  • 1 min read
In brief

Generating AI summary…

Ascendis plans a once-monthly obesity drug after its Novo deal ends
Ascendis plans a once-monthly obesity drug after its Novo deal ends

Ascendis plans multiple metabolic and cardiovascular programs, including TransCon Semaglutide for obesity and type 2 diabetes, with no continuing financial obligations.
continue reading...

Author
Google News

You May Also Like